Drosophila as a genetic model for studying pathogenic human viruses  by Hughes, Tamara T. et al.
Virology 423 (2012) 1–5
Contents lists available at SciVerse ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r .com/ locate /yv i roMinireview
Drosophila as a genetic model for studying pathogenic human viruses
Tamara T. Hughes, Amanda L. Allen, Joseph E. Bardin, Megan N. Christian, Kansei Daimon, Kelsey D. Dozier,
Caom L. Hansen, Lisa M. Holcomb, Joseph Ahlander ⁎
Department of Natural Sciences, Northeastern State University, Tahlequah, OK 74464, USA⁎ Corresponding author at: Northeastern State Univ
Sciences, 600 North Grand Avenue, Tahlequah, OK 7446
E-mail address: ahlander@nsuok.edu (J. Ahlander).
0042-6822/$ – see front matter © 2011 Elsevier Inc. All
doi:10.1016/j.virol.2011.11.016a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 September 2011
Returned to author for revision
22 September 2011
Accepted 21 November 2011
Available online 15 December 2011
Keywords:
Drosophila
Viruses
GAL4/UAS system
Transgenic expression
Model organism
Human pathogensViruses are infectious particles whose viability is dependent on the cells of living organisms, such as bacteria,
plants, and animals. It is of great interest to discover how viruses function inside host cells in order to develop
therapies to treat virally infected organisms. The fruit ﬂy Drosophila melanogaster is an excellent model sys-
tem for studying the molecular mechanisms of replication, ampliﬁcation, and cellular consequences of
human viruses. In this review, we describe the advantages of using Drosophila as a model system to study
human viruses, and highlight how Drosophila has been used to provide unique insight into the gene function
of several pathogenic viruses. We also propose possible directions for future research in this area.
© 2011 Elsevier Inc. All rights reserved.Introduction
Viral infection is associated with a number of diseases ranging
from the common cold to cancer. It is therefore of great interest to un-
derstand the molecular basis of viral infection and propagation to
minimize the threat of these viruses to human health.
During infection, viruses release their genetic material into the
host cell. These foreign genes are expressed, producing viral proteins
which hijack the molecular machinery of the host cell through inter-
actions with endogenous cellular proteins. One strategy for minimiz-
ing the damaging effects of a virus is to identify and inhibit the
molecular mechanisms by which viruses replicate in cells.
The fruit ﬂy Drosophila melanogaster is currently being used as a
genetic system to model many human diseases, such as Parkinson's
disease (Feany and Bender, 2000), heritable cancer syndromes such
as multiple endocrine neoplasia (Read et al., 2005), and metabolic
disorders like obesity and diabetes (Musselman et al., 2011). Drosoph-
ila has been used for decades to study the molecular and genetic func-
tions of a range of viruses, as well as giving important insight into the
mechanisms of host antiviral immunity (Sabin et al., 2010). Of partic-
ular note are a number of human viruses and their gene products that
have been studied using Drosophila (Table 1). For example, Drosophila
cells have been used in genome-wide RNA interference screens to
rapidly identify cellular factors required for replication of inﬂuenzaersity, Department of Natural
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rights reserved.and dengue viruses (Hao et al., 2008; Sessions et al., 2009). The dis-
covery of host factors involved in viral pathogenesis may lead to the
development of novel treatments.
In this article, we discuss how D. melanogaster can be used to study
viral gene function. We also review some of the published research
that has used Drosophila to study important human viral pathogens.
Finally, we suggest opportunities for future studies using this approach.
D. melanogaster as a model to study gene function
D. melanogaster has already proven to be a powerful tool for un-
derstanding the molecular function of viral proteins (Table 1). The
conserved genetic pathways between ﬂy and human combined with
the availability of numerous genetic resources to study gene function
makes D. melanogaster a natural model system to study molecular
mechanisms related to human biology (Reiter et al., 2001).
Drosophila possesses many characteristics desired in a model or-
ganism that allow rapid, meaningful analysis of viral gene function.
First, the genetics of the Drosophila are relatively simple. Drosophila
contains fewer genes than humans, indicating less overall genetic re-
dundancy. This allows for a simpler analysis when studying the ef-
fects of genes on biological processes (Dimova and Dyson, 2005;
Zhang et al., 2007). Second, these model organisms can be genetically
modiﬁed and propagated quickly. The developmental time of Dro-
sophila ranges from about one to three weeks and is dependent on
temperature and other environmental conditions. The entire lifespan
is approximately one month in length. In addition, female ﬂies can
produce hundreds of offspring within a couple of weeks, and those
Table 1
Human viruses studied using Drosophila melanogaster.
Virus Involvement in human disease Experimental systems used References
Dengue virus (DENV) Dengue fever, hemorrhagic fever Drosophila cell culture (infected) Mukherjee and Hanley (2010);
Sessions et al. (2009)
Epstein–Barr virus (EBV) Infectious mononucleosis, various
cancers, autoimmune disease
Live Drosophila (transgenic) Adamson et al. (2005)
Hepatitis B virus (HBV) Hepatitis B, liver cancer Drosophila cell culture (transfected) Wang et al. (1998)
Human immunodeﬁciency
virus 1 (HIV-1)
Acquired immune deﬁciency
syndrome (AIDS)
Drosophila cell culture (transfected),
live Drosophila (transgenic)
Battaglia et al. (2001); Brighty and
Rosenberg (1994); Chan et al. (2002);
Chaudhuri et al. (2007); Ivey-Hoyle and
Rosenberg (1990); Lee et al. (2005);
Leulier et al. (2003); Ponti et al. (2008)
Human cytomegalovirus (HCMV) Birth defects, mononucleosis,
severe complications in
immunocompromised individuals
Live Drosophila (transgenic) Steinberg et al. (2008)
Inﬂuenza A virus Flu pandemics, pneumonia,
respiratory failure
Drosophila cell culture (infected),
live Drosophila (transgenic)
Adamson et al. (2011); Chou et al.
(2007); Hao et al. (2008); Lam et al.
(2010); Li et al. (2004)
SARS coronavirus (SARS-CoV) Severe acute respiratory
syndrome (SARS)
Live Drosophila (transgenic) Chan et al. (2007, 2009); Wong et al.
(2005)
Simian vacuolating virus 40 (SV40) Possibly oncogenic Live Drosophila (transgenic) Kotadia et al. (2008)
Sindbis virus (SINV) Sindbis fever, Pogosta disease Drosophila cell culture (infected),
live Drosophila (infected)
Avadhanula et al. (2009); Brackney
et al. (2010); Galiana-Arnoux et al.
(2006); Mudiganti et al. (2006, 2010);
Rose et al. (2011); Sabin et al. (2009);
Saleh et al. (2009)
Vaccinia virus (VACV) Fever, rash, used as vaccine to
protect against smallpox
Drosophila cell culture (infected),
live Drosophila (infected, transgenic)
Chou et al. (2007); Li et al. (2004);
Moser et al. (2010); Sabin et al. (2009)
Vesicular stomatitis virus (VSV) Flu-like symptoms in humans,
usually infects livestock
Drosophila cell culture (infected),
live Drosophila (infected)
Cherry (2009); Mueller et al. (2010);
Sabin et al. (2009); Shelly et al. (2009)
West Nile virus (WNV) West Nile fever, encephalitis Drosophila cell culture (infected),
live Drosophila (infected)
Brackney et al. (2010); Chotkowski
et al. (2008); Glaser and Meola (2010)
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enabling the life cycle to start over once again. They are also convenient
to grow in the lab due to their small size and simple diet. Hence, large
numbers of ﬂies can be maintained inexpensively in the laboratory.
Third, the action of viral genes can be studied in the context of whole
Drosophila tissues in vivo, which more closely models the cellular envi-
ronment of viral infection. This is particularly valuable because the
effects of the virus at different stages of development can be explored.
Despite its many advantages, there are some limitations of using
Drosophila as a system to model human biology. First, there are phys-
iological differences between Drosophila and humans. For example,
the optimal temperature for culturing fruit ﬂies is between 18 °C
and 27 °C. On the other hand, the average body temperature of a
human is approximately 37 °C. Human viruses may be adapted for
optimal function at 37 °C, so some viral proteins may be unable to
function properly at temperatures lower than normal body human
temperature. Second, genetic differences between Drosophila and
humans may pose a challenge to using ﬂies for studying some
human viruses. Since genomic conservation is not comprehensive be-
tween humans and fruit ﬂies some genes found in humans are absent
in the Drosophila genome, which could make it difﬁcult to study some
viruses that may require host factors that are not found in Drosophila
cells. Finally, there are also biochemical differences between Drosoph-
ila and humans. For example, the inﬂuenza virus binds to a sialic acid
residue on the surface of human cells during infection. One study re-
quired that the inﬂuenza virus be modiﬁed using a different viral coat
protein to aid it in infecting Drosophila cells, since these insect cells
lacked the sialic acid necessary for viral entry (Hao et al., 2008). How-
ever, once inside the cell these viral genes are expressed and appear
to function similarly to when they are inside of human cells.
Undoubtedly, the differences between human and insect cells do
not necessarily need to become a permanent obstacle to the use of
Drosophila as a model system, as many limitations have been and
can be overcome through modiﬁcation of either the virus or the
host cells (Chaudhuri et al., 2007; Hao et al., 2008). Furthermore, an
alternative to altering viral coat proteins to allow infection would beto introduce viral genes into Drosophila cells through transfection or
transgenesis. However, rather than remaining a standalone system
to study viral mechanisms, Drosophila may be most beneﬁcial as a
tool to rapidly screen the in vivo function of viral genes followed by
complementary studies with mammalian cells.
The GAL4/UAS system for in vivo expression of viral transgenes
A strategy often used to express viral genes in Drosophila is the bi-
nary GAL4/UAS gene expression system. In this system a gene of in-
terest is constructed so that its expression is under the control of
the upstream activating sequence (UAS), which is activated by bind-
ing of the GAL4 transcription factor (Fig. 1). Drosophila expression
vectors are available to insert any gene of interest for the generation
of transgenic ﬂies and can efﬁciently accommodate genes greater
than 5 kb in size. In addition, there are publicly available ﬂy stocks
for hundreds of different inducible or tissue-speciﬁc GAL4 transgenes,
which permit precise control over transgene expression. Adult ﬂies
carrying a UAS-linked transgene aremated to ﬂies carrying a GAL4 driver,
producing progeny containing both elements of the system. The GAL4
gene can then induce expression of the gene of interest in a predictable
pattern in the organism. Transcription of the target gene requires the
presence of GAL4, so in its absence the gene of interest remains silent in
cells that do not express GAL4. One advantage of this system is the ability
to study toxic or lethal gene products by restricting transgene expression
to cells in non-essential tissues like the eye or wing (Duffy, 2002).
Mutant phenotypes generated by transgenic expression of gene
products such as viral proteins can be used to study the molecular
and genetic mechanisms that underpin the function of those genes.
Such gain-of-function phenotypes are particularly amenable to
genetic screens to uncover the cellular host factors involved in the
regulation of viral pathogenesis. In addition, a library of drug
compounds may be fed to developing ﬂies to discover inhibitors of
the mutant phenotypes caused by the viral proteins being studied.
Such pharmacological screens have the potential to discover new
candidate drugs for the treatment of viral infections.
Fig. 1. The GAL4/UAS system can be used to express foreign viral proteins in vivo in
Drosophila melanogaster. A gene of interest is placed next to the upstream activating se-
quence (UAS), which allows activation of gene expression by the GAL4 transcription
factor. Flies with a UAS-responsive transgene are crossed with other ﬂies with a specif-
ic GAL4 driver gene. In this illustrated example, the offspring has a GAL4 gene under
control of the actin promoter, which expresses GAL4 ubiquitously throughout develop-
ment. GAL4 then binds to UAS and turns on the viral gene in all cells that express GAL4.
If expression had to be targeted to a speciﬁc subset of cells, then a different GAL4 line
would be used to restrict viral gene expression to speciﬁc tissues. For example, GAL4
expression could be targeted to the eye where the viral gene would only be expressed
in those cells but not in the other tissues of the organism.
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genes to ensure robust gene expression inDrosophila. First, it is impor-
tant that these genes are expressed at sufﬁcient levels in Drosophila
cells, since the level of transgene expression can have a signiﬁcant ef-
fect on phenotypes. A single transgene is sometimes not sufﬁcient to
produce a phenotype or produces a weak phenotype with low pene-
trance. However, GAL4 activity is temperature sensitive, so raising
the rearing temperature of the ﬂies a few degrees can enhance expres-
sion (Duffy, 2002). Such a shift in temperature may also have a posi-
tive effect on the activity of human viral proteins, since these
typically function under the higher physiological temperature of the
human body. Furthermore, stronger expression through an increase
of the transgene copy number can also help to generate a phenotype
(Asano and Wharton, 1999; Hong et al., 2008). However, improved
expression vectors for making transgenic ﬂies have been generated
that increase transgene expression several fold over previous con-
structs, which in some cases will eliminate the need to combine mul-
tiple copies of transgenes to boost expression (Pfeiffer et al., 2010).
Second, codon optimization of viral gene sequences should also be
considered when constructing transgenes for expression in heterolo-
gous hosts (Welch et al., 2011). The D. melanogaster genome shows a
preference for particular codons compared to other organisms, a phe-
nomenon called codon bias, and it is presumed that genes that en-
code proteins using rare codons will be translated at a slower rate.
In other words, a gene that expresses well in one host species may
express poorly in a different species, so using codon optimization
for the target species may improve translation efﬁciency. Indeed,
codon optimization of enhanced green ﬂuorescent protein (EGFP)
for expression in Drosophila resulted in a 50% increase in EGFP pro-
duction compared to the standard coding sequence (Pfeiffer et al.,
2010). Codon optimized gene sequences can be generated in-house
through site-directed mutagenesis, or alternatively they can be com-
mercially synthesized de novo.Third, like the Kozak consensus sequence used for efﬁcient transla-
tion initiation inmammalian genes, highly expressedDrosophila genes
also have the Kozak-like sequence CAAAAUG (Cavener, 1987). Inclu-
sion of this sequence in viral gene constructs may enhance translation
initiation and increase protein expression levels. Together these ge-
netic engineering strategies may enhance expression of viral trans-
genes in Drosophila to greatly advance functional study of these genes.
Investigators should be aware that special approval may be re-
quired by governmental agencies beforemaking transgenic organisms
to study gene sequences from some viruses, particularly those viruses
that are regarded as potential bioterrorism threats. Examples of these
would likely include some viruses that cause hemorrhagic fever or en-
cephalitis. The genes of many viruses, however, may be freely permit-
ted for use in making transgenic insects. For example, in the United
States, the National Institutes of Health allows the generation of trans-
genic invertebrates with DNA derived from most eukaryotic viruses,
as long as it contains less than two-thirds of the viral genome and can-
not lead to the production of infectious viruses (NIH, 2011). These is-
sues should be carefully considered during the design of experiments
to study pathogenic viruses using insect systems.
Studies of human viruses using D. melanogaster
Numerous studies have shown that D. melanogaster is a valuable
system for studying human viruses (Table 1). Here we review a few
of these studies that highlight the efﬁcacy of this approach. Speciﬁcal-
ly, we summarize important ﬁndings that helped to advance under-
standing of the SARS and HIV viruses.
SARS
Severe Acute Respiratory Syndrome corona virus (SARS-CoV) was
the cause of a worldwide pneumonia outbreak in 2003 (Rota et al.,
2003). SARS is an enveloped, single-stranded RNA virus that infects
tissues of the intestines and lungs via air-borne transmission (Chen
et al., 2011). An effective drug to treat SARS is still being pursued,
since most pharmaceutical treatment of SARS patients so far have
proven ineffective (Stockman et al., 2006). Research using D. melano-
gaster has elucidated how SARS-CoV proteins function within the cel-
lular environment.
In vivo expression of the SARS-CoV 3a protein using transgenic
Drosophila caused an increase in apoptosis in the developing eye
(Wong et al., 2005). Genetic interaction studies with these ﬂies fur-
ther showed that apoptosis caused by 3a expression occurred
through the mitochondrial pathway via cytochrome c, and this result
was later validated using human cells (Padhan et al., 2008). Through
the use of genetic modiﬁer screens, the function of 3a was also linked
to other cellular processes, including calcium regulation, ubiquitina-
tion, and transcription (Wong et al., 2005). A subsequent report stud-
ied structure–function relationships of the 3a protein using a
combination of experiments with human cell culture and transgenic
Drosophila (Chan et al., 2009). Importantly, pharmaceutical blockage
of the 3a ion channel activity prevents its ability to induce apoptosis
both in vitro (human cells) and in vivo (transgenic Drosophila). Anoth-
er study using transgenic ﬂies showed that the SARS-CoV membrane
(M) protein induces apoptosis in the eye by suppressing survival sig-
naling pathways (Chan et al., 2007). Thus, research in Drosophila has
identiﬁed novel cellular targets that may be useful for future research
to discover drugs that control the activity of these SARS-CoV proteins,
leading to treatments that could alleviate symptoms and limit the
spread of this disease.
HIV
More than 30 million individuals are infected with the human im-
munodeﬁciency virus (HIV) worldwide, resulting in about 2 million
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that uses its own reverse transcriptase to replicate its genomic
single-stranded RNA through a DNA intermediate. During its life
cycle, this viral DNA can become permanently integrated into the
host cell DNA where its genes are expressed (Cherepanov et al.,
2011). The virus is generally spread through sexual contact or contact
with blood products. Although antiviral drugs can suppress the infec-
tion for many years, there is currently no cure for HIV. In an effort to
better understand this virus, D. melanogaster has been used to study
the function of genes from HIV-1. Described below are examples of
three different HIV-1 genes whose functions were further clariﬁed
using Drosophila. These studies highlight the strength and versatility
of this genetic model system.
HIV-1 Nef is a membrane-associated protein involved in the
downregulation of the cell surface receptor CD4 through endocytosis
(Garcia and Miller, 1991). Human CD4 and HIV-1 Nef proteins were
co-expressed in cultured Drosophila S2 cells, where Nef was shown
to downregulate CD4 (Chaudhuri et al., 2007). Using RNA interfer-
ence to target cellular factors involved in protein trafﬁcking, it was
revealed that Nef-dependent CD4 downregulation required a speciﬁc
interaction with AP2, a complex involved in clathrin-mediated endo-
cytosis, but not other AP complexes. This discovery was followed up
using HeLa cells where it was shown that the Nef-AP2 interaction is
functionally conserved in humans. Another study used transgenic
Drosophila to show that Nef expression in larval wing discs also
caused apoptosis through activation of the conserved JNK signaling
pathway (Lee et al., 2005). In addition, Nef expression negatively af-
fected the Drosophila immune system by inhibiting NF-κB signaling
in fat body cells. These ﬁndings may help to explain how Nef expres-
sion during HIV infection contributes to the decline of T-cell immune
function that is characteristic of AIDS progression.
Tat is an HIV-1 protein required for viral gene expression and is
essential for viral replication. Tat was expressed in transgenic Dro-
sophila, where it disrupted microtubule polymerization and kineto-
chore dynamics via a direct interaction with tubulin (Battaglia et al.,
2001). Ensuing research in human cells validated the importance of
this ﬁnding that helped to advance the understanding of the mecha-
nisms of HIV pathogenesis (Butler et al., 2011; Chen et al., 2002).
Tat was previously shown to localize to nucleoli in human cells, but
the function of Tat in the nucleolus was unclear. Another study dem-
onstrated that expression of Tat protein in the Drosophila ovary
showed nucleolar localization (Ponti et al., 2008). In these transgenic
females, Tat was shown to affect the maturation of ribosomes through
the inhibition of rRNA processing, which resulted in a reduced num-
ber of ribosomes in the cytoplasm. Many viruses regulate protein pro-
duction to facilitate viral replication and to modulate the apoptotic
response of the host cell, so this research suggests a mechanism by
which Tat may play a role in HIV-1 pathogenesis.
HIV-1 Rev is a protein that has been shown to regulate expression
of HIV proteins, for example by facilitating export and translation of
viral env mRNA. Rev was studied in cultures of Drosophila S2 cells
through the use of a Rev gene co-transfected with a plasmid contain-
ing a copy of the viral env gene (Ivey-Hoyle and Rosenberg, 1990). It
was found that Rev acts in Drosophila cells as it does in mammalian
cells by promoting the transport of env mRNA from the nucleus to
the cytoplasm. This suggests that the Rev protein functions by inter-
acting with host cellular factors that are conserved between humans
and insects (Brighty and Rosenberg, 1994). Future research will ben-
eﬁt from using Drosophila to study HIV protein function due to the
high conservation between insect and human cellular pathways.
Future directions
D. melanogaster has proven to be an excellent system for studying
the pathogenic mechanisms of human viruses. However, we believe
that this tool remains underutilized and holds great potential forthe study of other human viruses. Viruses that would make good can-
didates for future study in Drosophilawould include those that have a
large impact on human populations. A small viral genome would
allow for a simpler selection of candidate genes for further study. In
addition, viruses that have known strains of different pathogenic
characteristics (HIV, HPV, etc.) may also be good candidates for
study. For example, a comparison of the functional differences be-
tween genes of the different strains could help to uncover what
makes one strain more pathogenic than another. Based on these cri-
teria, we have identiﬁed three candidates – the human papillomavi-
rus, the hepatitis C virus, and the yellow fever virus – which could
potentially beneﬁt from studies using Drosophila as a model. We an-
ticipate that in the future D. melanogaster will prove to be a produc-
tive system for uncovering the molecular mechanisms of these and
other pathogenic human viruses.
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